Hepatitis Monthly

Published by: Kowsar

Development of an In-House TaqMan Real Time RT-PCR Assay to Quantify Hepatitis C Virus RNA in Serum and Peripheral Blood Mononuclear Cells in Patients With Chronic Hepatitis C Virus Infection

Bahman Khalvati Fahlyani 1 , Abbas Behzad-Behbahani 1 , 2 , * , Seiied Alireza Taghavi 3 , Ali Farhadi 1 , 2 , Saeede Salehi 1 , 2 , Setare Adibzadeh 1 , 2 , Farzaneh Aboualizadeh 1 , Parniyan Alavi 1 , Negin Nikouyan 1 , Mohammad Ali Okhovat 1 , Reza Ranjbaran 1 , Gholam Reza Rafiei Dehbidi 1 and Arash Shakibzadeh 1
Authors Information
1 Diagnosis Laboratory Sciences and Technology Research Center, School of Paramedical, Sciences Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Department of Biotechnology, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Hepatitis Monthly: August 01, 2015, 15 (8); e28895
  • Published Online: August 31, 2015
  • Article Type: Research Article
  • Received: March 29, 2015
  • Revised: August 2, 2015
  • Accepted: August 12, 2015
  • DOI: 10.5812/hepatmon.28895

To Cite: Khalvati Fahlyani B, Behzad-Behbahani A, Taghavi S A, Farhadi A, Salehi S, et al. Development of an In-House TaqMan Real Time RT-PCR Assay to Quantify Hepatitis C Virus RNA in Serum and Peripheral Blood Mononuclear Cells in Patients With Chronic Hepatitis C Virus Infection, Hepat Mon. 2015 ; 15(8):e28895. doi: 10.5812/hepatmon.28895.

Copyright © 2015, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Moradpour D, Penin F, Rice CM. Replication of hepatitis C virus. Nat Rev Microbiol. 2007; 5(6): 453-63[DOI][PubMed]
  • 2. Lindsay KL. Introduction to therapy of hepatitis C. Hepatology. 2002; 36(5 Suppl 1)-20[DOI][PubMed]
  • 3. Lau DT, Kleiner DE, Ghany MG, Park Y, Schmid P, Hoofnagle JH. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. Hepatology. 1998; 28(4): 1121-7[DOI][PubMed]
  • 4. Pearlman BL, Traub N. Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more. Clin Infect Dis. 2011; 52(7): 889-900[DOI][PubMed]
  • 5. Laskus T, Radkowski M, Wang LF, Jang SJ, Vargas H, Rakela J. Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology. 1998; 248(1): 164-71[DOI][PubMed]
  • 6. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005; 5(9): 558-67[DOI][PubMed]
  • 7. Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol. 2004; 78(11): 5867-74[DOI][PubMed]
  • 8. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology. 2005; 41(1): 106-14[DOI][PubMed]
  • 9. Radkowski M, Horban A, Gallegos-Orozco JF, Pawelczyk A, Jablonska J, Wilkinson J, et al. Evidence for viral persistence in patients who test positive for anti-hepatitis C virus antibodies and have normal alanine aminotransferase levels. J Infect Dis. 2005; 191(10): 1730-3[DOI][PubMed]
  • 10. Hadinedoushan H, Salmanroghani H, Amirbaigy MK, Akhondi-Meybodi M. Hepatitis C virus genotypes and association with viral load in yazd, central province of iran. Hepat Mon. 2014; 14(3)[DOI][PubMed]
  • 11. Mackay IM, Arden KE, Nitsche A. Real-time PCR in virology. Nucleic Acids Res. 2002; 30(6): 1292-305[PubMed]
  • 12. Scott JD, Gretch DR. Molecular diagnostics of hepatitis C virus infection: a systematic review. JAMA. 2007; 297(7): 724-32[DOI][PubMed]
  • 13. Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S, et al. Protection against persistence of hepatitis C. Lancet. 2002; 359(9316): 1478-83[DOI][PubMed]
  • 14. Yang JH, Lai JP, Douglas SD, Metzger D, Zhu XH, Ho WZ. Real-time RT-PCR for quantitation of hepatitis C virus RNA. J Virol Methods. 2002; 102(1-2): 119-28[PubMed]
  • 15. Castelain S, Descamps V, Thibault V, Francois C, Bonte D, Morel V, et al. TaqMan amplification system with an internal positive control for HCV RNA quantitation. J Clin Virol. 2004; 31(3): 227-34[DOI][PubMed]
  • 16. Morandi L, Ferrari D, Lombardo C, Pession A, Tallini G. Monitoring HCV RNA viral load by locked nucleic acid molecular beacons real time PCR. J Virol Methods. 2007; 140(1-2): 148-54[DOI][PubMed]
  • 17. Daniel HD, David J, Grant PR, Garson JA, Chandy GM, Abraham P. Whole blood as an alternative to plasma for detection of hepatitis C virus RNA. J Clin Microbiol. 2008; 46(11): 3791-4[DOI][PubMed]
  • 18. Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology. 2006; 44(1): 15-22[DOI][PubMed]
  • 19. Boisvert J, He XS, Cheung R, Keeffe EB, Wright T, Greenberg HB. Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis. 2001; 184(7): 827-35[DOI][PubMed]
  • 20. MacParland SA, Pham TN, Guy CS, Michalak TI. Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro. Hepatology. 2009; 49(5): 1431-41[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments